Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients

NCT02866383 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Cancer
Metastatic Biliary Tract Cancer

Interventions

DRUG: Nivolumab
DRUG: Ipilimumab
RADIATION: Radiotherapy

Sponsor

Herlev Hospital

Collaborators

[object Object]